Chemoinformaics analysis of 16-HYDROXY-HEXADECANOIC-ACID
Molecular Weight | 325.537 | nRot | 15 |
Heavy Atom Molecular Weight | 286.225 | nRig | 5 |
Exact Molecular Weight | 325.298 | nRing | 1 |
Solubility: LogS | -6.322 | nHRing | 1 |
Solubility: LogP | 6.716 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 39 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 62.1089 |
nHD | 1 | BPOL | 42.0011 |
QED | 0.395 |
Synth | 2.552 |
Natural Product Likeliness | 0.541 |
NR-PPAR-gamma | 0.013 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.001 |
HIA | 0.002 |
CACO-2 | -4.79 |
MDCK | 0.0000148 |
BBB | 0.346 |
PPB | 0.854845 |
VDSS | 2.249 |
FU | 0.120077 |
CYP1A2-inh | 0.184 |
CYP1A2-sub | 0.339 |
CYP2c19-inh | 0.358 |
CYP2c19-sub | 0.144 |
CYP2c9-inh | 0.061 |
CYP2c9-sub | 0.856 |
CYP2d6-inh | 0.862 |
CYP2d6-sub | 0.167 |
CYP3a4-inh | 0.633 |
CYP3a4-sub | 0.178 |
CL | 3.824 |
T12 | 0.137 |
hERG | 0.031 |
Ames | 0.005 |
ROA | 0.013 |
SkinSen | 0.952 |
Carcinogencity | 0.132 |
EI | 0.823 |
Respiratory | 0.946 |
NR-Aromatase | 0.319 |
Antiviral | Yes |
Prediction | 0.594568 |